Search Results - van Ballegooijen, M.

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions by Kroep, S., Lansdorp_Vogelaar, Iris, Van Der Steen, A., Inadomi, J., Van Ballegooijen, M.

Get full text

Contribution of screening and survival differences to racial disparities in colorectal cancer rates by Lansdorp_Vogelaar, Iris, Kuntz, K., Knudsen, A., Van Ballegooijen, M., Zauber, A., Jemal, A.

Get full text

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study by Van Hees, F., Zauber, A., Klabunde, C., Goede, S., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M.

Get full text

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? by Wilschut, J., Steyerberg, E., Van Leerdam, M., Lansdorp_Vogelaar, Iris, Habbema, J., Van Ballegooijen, M.

Get full text

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study by Van Der Meulen, M., Lansdorp_Vogelaar, Iris, Van Heijningen, E., Kuipers, E., Van Ballegooijen, M.

Get full text

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis by Van Hees, F., Habbema, D., Meester, R., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M., Zauber, A.

Get full text

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling by Kroep, S., Lansdorp_Vogelaar, Iris, Rubenstein, J., de Koning, H., Meester, R., Inadomi, J., van Ballegooijen, M.

Get full text

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences by Lansdorp_Vogelaar, Iris, Goede, S., Ma, J., Xiau-Cheng, W., Pawlish, K., Van Ballegooijen, M., Jemal, A.

Get full text

Fecal occult blood testing when colonoscopy capacity is limited by Wilschut, J., Habbema, J., Van Leerdam, M., Hol, L., Lansdorp_Vogelaar, Iris, Kuipers, E., Van Ballegooijen, M.

Get full text

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression by Kuntz, K., Lansdorp_Vogelaar, Iris, Rutter, C., Knudsen, A., Van Ballegooijen, M., Savarino, J., Feuer, E., Zauber, A.

Get full text

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness by Van Hees, F., Saini, S., Lansdorp_Vogelaar, Iris, Vijan, S., Meester, R., De Koning, H., Zauber, A., Van Ballegooijen, M.

Get full text

Colorectal cancer deaths attributable to nonuse of screening in the United States by Meester, R., Doubeni, C., Lansdorp_Vogelaar, Iris, Goede, S., Levin, T., Quinn, V., van Ballegooijen, M., Corley, D., Zauber, A.

Get full text

Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands by Kroep, S., Lansdorp_Vogelaar, Iris, Rubenstein, J., Lemmens, V., Van Heijningen, E., Aragonés, N., Van Ballegooijen, M., Inadomi, J.

Get full text

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening by Goede, S., Rabeneck, L., Van Ballegooijen, M., Zauber, A., Paszat, L., Hoch, J., Yong, J., Kroep, S., Tinmouth, J., Lansdorp_Vogelaar, Iris

Get full text

Developing a score chart to improve risk stratification of patients with colorectal adenoma by Van Heijningen, E., Lansdorp_Vogelaar, Iris, Van Hees, F., Kuipers, E., Biermann, K., De Koning, H., Van Ballegooijen, M., Steyerberg, E.

Get full text

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening by Wilschut, J., Hol, L., Dekker, E., Jansen, J., Van Leerdam, M., Lansdorp_Vogelaar, Iris, Kuipers, E., Habbema, J., Van Ballegooijen, M.

Get full text

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands by Van Hees, F., Zauber, A., Van Veldhuizen, H., Heijnen, M., Penning, C., De Koning, H., Van Ballegooijen, M., Lansdorp_Vogelaar, Iris

Get full text

Cost-savings to medicare from pre-medicare colorectal cancer screening by Goede, S., Kuntz, K., Van Ballegooijen, M., Knudsen, A., Lansdorp_Vogelaar, Iris, Tangka, F., Howard, D., Chin, J., Zauber, A., Seeff, L.

Get full text

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines by Rutter, C., Knudsen, A., Marsh, T., Doria-Rose, V., Johnson, E., Pabiniak, C., Kuntz, K., Van Ballegooijen, M., Zauber, A., Lansdorp_Vogelaar, Iris

Get full text

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening by Goede, S., Van Roon, A., Reijerink, J., Van Vuuren, A., Lansdorp_Vogelaar, Iris, Habbema, J., Kuipers, E., Van Leerdam, M., Van Ballegooijen, M.

Get full text